Bifunctional stapled polypeptides and uses thereof
US-9163330-B2 · Oct 20, 2015 · US
US9505801B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9505801-B2 |
| Application number | US-201314068844-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2013 |
| Priority date | May 18, 1999 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides novel stabilized crosslinked compounds having secondary structure motifs, libraries of these novel compounds, and methods for the synthesis of these compounds libraries thereof. The synthesis of these novel stabilized compounds involves (1) synthesizing a peptide from a selected number of natural or non-natural amino acids, wherein the peptide comprises at least two moieties capable of undergoing reaction to promote carbon-carbon bond formation; and (2) contacting the peptide with a reagent to generate at least one crosslinker and to effect stabilization of a secondary structure motif. The present invention, in a preferred embodiment, provides stabilized p53 donor helical peptides. Additionally, the present invention provides methods for disrupting the p53/MDM2 binding interaction comprising (1) providing a crosslinked stabilized α-helical structure; and (2) contacting the crosslinked stabilized α-helical structure with MDM2.
Opening claim text (preview).
We claim: 1. A method for disrupting the binding of a p53 protein to an MDM2 protein, the method comprising contacting a peptide with the MDM2 protein, wherein the peptide comprises at least two amino acids connected by a hydrocarbon covalent cross-link that stabilizes a secondary structure an α-helix of the peptide. 2. The method of claim 1 , further comprising contacting the peptide with the p53 protein. 3. The method of claim 1 , wherein the peptide comprises an MDM2 binding site of a p53 donor helix. 4. The method of claim 1 , wherein the cross-link comprises a carbon-carbon double bond. 5. The method of claim 1 , wherein at least one amino acid in the peptide is a non-natural amino acid. 6. The method of claim 1 , wherein the at least two amino acids in the peptide comprise olefins. 7. The method of claim 1 , wherein the at least two amino acids that are connected by the hydrocarbon covalent cross-link are alpha,alpha-methyl, vinyl; alpha, alpha-methyl, alkylolefin; or divinyl amino acids. 8. The method of claim 7 , wherein the alpha, alpha-disubstituted amino acids that are connected by the hydrocarbon covalent cross-link are positioned at i,i+4 or at i,i+7. 9. The method of claim 7 , wherein at least one amino acid that is connected by the hydrocarbon covalent cross-link comprises an alpha-methyl, alpha-alkenyl amino acid. 10. The method of claim 9 , wherein the alpha-methyl, alpha-alkenyl amino acid comprises a n-pentenyl or n-octenyl side chain. 11. The method of claim 1 , wherein the cross-link spans from one to two turns on an α-helix. 12. The method of claim 1 , wherein the length of the cross-link between the two α positions is 7 or 8 carbon atoms. 13. The method of claim 1 , wherein the length of the cross-link between the two α positions is 9 to 12 carbon atoms. 14. The method of claim 1 , wherein the length of the cross-link between the two α positions is 11 carbon atoms. 15. The method of claim 1 , wherein the cross-linked peptide exhibits increased helicity compared to an uncrosslinked peptide. 16. The method of claim 1 , wherein the cross-link is generated by a transition metal catalyzed cross-coupling reaction.
by chemical synthesis · CPC title
using coupling agents {(C07K1/006 takes precedence)} · CPC title
Peptides of undefined number of amino acids; Derivatives thereof · CPC title
on carriers {(C07K1/003, C07K1/006 take precedence)} · CPC title
Simultaneous synthesis of different peptide species; Peptide libraries · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.